AOD 9604: Peptide Claims vs Clinical Reality AOD 9604 is marketed as a fat metabolism peptide derived from a growth hormone fragment, often positioned as HGH like without HGH's side effects. The clinical question AOD 9604 had six human trials and 900 participants. Phase IIa showed positive results. Then the pivotal Phase IIb failed at every dose tested. Development was terminated in 2007. The trial history is AOD9604 Versus GLP1 Fat Loss Consensus AOD 9604: Revolutionary peptide for fat loss and joint health Peptides Robertson Wellness & Aesthetics
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
aod9604 clinical trials results AOD-9604 Safety Profile: What Clinical Trials Show